Table 5.3 ¨C Hepatitis B & Hepatitis C for 18¨C40 Years

At a glance

This table summarizes the numbers of reported cases and rates of acute hepatitis B and acute hepatitis C among persons aged 18–40 years for 2022. Persons aged 18–40 years were used as a proxy for persons who inject drugs.
2022 Hepatitis Surveillance Appendix

Numbers and rates* of reported cases of acute hepatitis B and acute hepatitis C among adults aged 18–40 years old, by demographic characteristics — United States, 2022

The number of reported cases and rates of acute hepatitis B and acute hepatitis C among persons aged 18–40 years for 2022.
Characteristics Acute hepatitis B Acute hepatitis C
No. Rate* No. Rate*
Total§ 582 0.6 2,678 2.7
Sex
Male 324 0.6 1,749 3.4
Female 257 0.5 928 1.9
Race/ethnicity
American Indian/Alaska Native, non-Hispanic 2 0.2 46 6.7
Asian/Pacific Islander, non-Hispanic 18 0.2 25 0.3
Black, non-Hispanic 131 0.9 269 1.9
White, non-Hispanic 297 0.5 1,628 3.0
Hispanic 91 0.4 307 1.4
Other 19 n/a 137 n/a
HHS region
Region 1: Boston 28 0.6 190 4.1
Region 2: New York 24 0.3 262 3.0
Region 3: Philadelphia 68 0.7 228 2.4
Region 4: Atlanta 304 1.5 1,070 5.2
Region 5: Chicago 67 0.4 385 2.4
Region 6: Dallas 39 0.3 158 1.1
Region 7: Kansas City 13 0.3 22 0.5
Region 8: Denver 10 0.2 202 4.8
Region 9: San Francisco 16 0.1 86 0.6
Region 10: Seattle 13 0.3 75 1.7

Source: ÐÇ¿ÕÓéÀÖ¹ÙÍø, National Notifiable Diseases Surveillance System.

* Rate per 100,000 population.

† Reported confirmed cases. For case definitions, see .

§ Numbers reported in each category may not add up to the total number of reported cases in a year due to cases with missing data.

¶ US Department of Health and Human Services regions were categorized according to the grouping of states and US territories assigned under each of the 10 . For the purposes of this report, regions with US territories (Region 2 and Region 9) contain data from states only.

n/a: Not applicable. Rate cannot be calculated due to lack of corresponding denominator.

Summary

The numbers of reported cases and rates of acute hepatitis B and acute hepatitis C among persons aged 18–40 years for 2022. Persons aged 18–40 years were used as a proxy for persons who inject drugs.